Capital Analysts LLC’s ResMed RMD Stock Holding History

Capital Analysts LLC’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Buy	+3	New	+$748	﹤0.01%	1521
2015 Q3	–	Sell	-44,051	Closed	-$2.48M	–	379
2015 Q2	$2.48M	Buy	44,051 +1,843	+4%	+$116K	0.51%	50
2015 Q1	$3.03M	Sell	42,208 -6,244	-13%	-$406K	0.63%	31
2014 Q4	$2.72M	Buy	48,452 +1,157	+2%	+$60.4K	0.6%	34
2014 Q3	$2.33M	Buy	47,295 +2,468	+6%	+$126K	0.55%	41
2014 Q2	$2.27M	Buy	44,827 +2,727	+6%	+$135K	0.55%	37
2014 Q1	$1.88M	Buy	+42,100	New	+$1.89M	0.49%	54

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Analysts LLC's RMD Position: Q1 2026 in Review

Capital Analysts LLC opened a new position in ResMed (RMD) in Q1 2026: 3 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Capital Analysts LLC previously reported a position in RMD as recently as Q2 2015.

Capital Analysts LLC first reported a position in RMD in Q1 2014 and has held it in 7 quarters since. The position peaked at $3.03M in Q1 2015. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Capital Analysts LLC held 3 shares of ResMed worth $1K as of Q1 2026.
ResMed was a new Capital Analysts LLC position in Q1 2026.
ResMed made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1521 holding.
Capital Analysts LLC first reported a position in ResMed in Q1 2014 and has held it in 7 quarters since.
Capital Analysts LLC's ResMed position peaked at $3.03M in Q1 2015.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.